ObstetricsIntermediate

Anti-D Immune Globulin (RhoGAM) Dosing & Kleihauer-Betke FMH Calculator

Calculates fetal-maternal hemorrhage (FMH) volume and ACOG-recommended 300 mcg RhoGAM vials.

Clinical Parameters

3 Variables

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
Advertisement
High Yield Prometric TopicObstetrics & Gynecology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like Anti-D Immune Globulin (RhoGAM) Dosing & Kleihauer-Betke FMH Calculator frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the Anti-D Immune Globulin (RhoGAM) Dosing & Kleihauer-Betke FMH Calculator?

📋Clinical Summary & Definition Capsule

The Anti-D Immune Globulin (RhoGAM) Dosing & Kleihauer-Betke FMH Calculator is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in obstetrics & gynecology practice. Implements the American College of Obstetricians and Gynecologists (ACOG) and College of American Pathologists (CAP) standards to calculate fetal whole blood volume (mL) from the Kleihauer-Betke (KB) acid-elution test, determining the exact number of 300 mcg (1500 IU) Anti-D immune globulin vials required including safety margin rounding. Clinical scoring tools like Anti-D Immune Globulin (RhoGAM) Dosing & Kleihauer-Betke FMH Calculator are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

Prevents hemolytic disease of the fetus and newborn (HDFN / erythroblastosis fetalis) in subsequent pregnancies by eliminating circulating fetal Rh+ D antigens.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate Anti-D Immune Globulin (RhoGAM) Dosing & Kleihauer-Betke FMH Calculator:

Fetal Whole Blood (mL) = (% Fetal RBCs in KB ÷ 100) × Maternal Blood Volume (mL)
Raw Vials = Fetal Whole Blood (mL) ÷ 30 mL
ACOG Rounding = Decimal < 0.5 → Round Down + 1 | Decimal ≥ 0.5 → Round Up + 1
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 1Standard Single Dose (1 Vial / 300 mcg [1500 IU])green
2 – 3Moderate FMH (2–3 Vials of 300 mcg)yellow
≥ 4Massive Fetal-Maternal Hemorrhage (≥ 4 Vials / High Isoimmunization Risk)red
Clinical Limitations & Contraindications

When to Exercise Caution

Maternal hemoglobinopathies with elevated Hemoglobin F (e.g., Hereditary Persistence of Fetal Hemoglobin [HPFH], Beta-Thalassemia minor) can falsely elevate KB counts; flow cytometry with anti-HbF/anti-D is diagnostic.

Sponsored Content
Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-08-08

Peer-Reviewed Medical Literature

  • American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017;130(2):e57-e70.
  • Kleihauer E, Braun H, Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr. 1957;35(12):637-638.
  • College of American Pathologists (CAP) Transfusion Medicine Resource Committee. Fetal-Maternal Hemorrhage Testing Guidelines. 2021.
Advertisement